The present disclosure relates to the field of analysis of a sample and more particularly to the field of visualization of components in a blood sample.
Analysis of blood samples, for example blood smears, is performed to determine one or more characteristics associated with the blood sample. Such characteristics may include determination of number of White Blood Cells (WBCs) and Red Blood Cells (RBCs) in the blood sample. Currently, analysis of blood smears is performed using microscopes manually or with automated microscopic slide scanners. Automated slide scanners enable automation of scanning workflow of microscopic slides. The scanners may raster scan a given area on a microscopic slide containing the blood smear. Such scanning of microscopic slides involves use of a high magnification/resolution microscope objective lens, for example 40× or 100× objective lens. In some cases, immersion oil may also be used to improve the magnification. Such configuration of the microscope is chosen because the number of White Blood Cells (WBCs) is sparse compared to Red Blood Cells (RBCs) with about one WBC for every 600-1000 RBCs. As increase in magnification decreases the field of view of the microscope, the microscopic slides may have to be scanned for a longer period of time and also several times to accurately determine the number of RBCs and WBCs. Furthermore, there is no way of easily sorting the blood cells that allows for easier and faster counting of blood cells. Therefore, manual scanning of slides under the microscope can be a time consuming and labor intensive process. Additionally, automated slide scanners include precision mechanical components and therefore are expensive.
Thus, there is no way of visualizing blood cells in a wide field of view with high resolution that is inexpensive and fast. Traditional imaging techniques also do not provide a way of computationally improving image resolution of the microscopic slide. Therefore, there exists a need for an efficient way of visualizing a blood sample that offers a wide field of view and enables faster sorting of blood cells.
A device for visualization of one or more components in a blood sample is disclosed. In one aspect of the invention, the device includes an imaging module. The imaging module includes a controllable illumination source which is capable of emitting light in plurality of discrete angles. The imaging module further includes a tube lens, one or more objective lens and an image capturing module. Additionally, the device includes a channel configured to carry the blood sample, wherein the channel is capable of sorting the one or more components in the blood sample.
This summary is provided to introduce a selection of concepts in a simplified form that are further described below in the following description. It is not intended to identify features or essential features of the claimed subject matter. Furthermore, the claimed subject matter is not limited to implementations that solve any or all disadvantages noted in any part of this disclosure.
The present invention is further described hereinafter with reference to illustrated embodiments shown in the accompanying drawings, in which:
Hereinafter, embodiments for carrying out the present invention are described in detail. The various embodiments are described with reference to the drawings, wherein like reference numerals are used to refer to like elements throughout. In the following description, for purpose of explanation, numerous specific details are set forth in order to provide a thorough understanding of one or more embodiments. It may be evident that such embodiments may be practiced without these specific details. In other instances, well known materials or methods have not been described in detail in order to avoid unnecessarily obscuring embodiments of the present disclosure. While the disclosure is susceptible to various modifications and alternative forms, specific embodiments thereof are shown by way of example in the drawings and will herein be described in detail. It should be understood, however, that there is no intent to limit the disclosure to the particular forms disclosed, but on the contrary, the disclosure is to cover all modifications, equivalents, and alternatives falling within the spirit and scope of the present disclosure. Disclosed embodiments provide device for analyzing an image. In particular, the device may enable visualization of one or more components in a blood sample.
In an embodiment, the imaging module 110 is a Fourier ptychography microscope. Fourier ptychography is a computational imaging technique where phase information associated with the one or more components on the microscopic slide can be computationally derived. Phase information is a representation of refractive index changes observed when light 107 passes through the one or more components in the microfluidic channel 103. Phase information of the one or more components can be used to differentiate areas of enhanced density or refractive index in the microfluidic channel 103, such as nuclei of WBCs. Red blood cells (RBCs) and WBCs have unique phase profiles owing to the morphological differences between the cells. Such differences in phase information can be used to identify cell features such as nuclei of WBCs. Fourier ptychography microscopy provides for a wide field of view and high resolution imaging. Wide field of view enables visualizing more blood cells at a given point in time. Therefore, analysis of the microfluidic channel 103 is faster and simpler. As Fourier ptychography microscopy enables illumination of the microfluidic channel 103 at different angles, high diffraction orders of the blood sample can be collected. Such diffraction orders can be computationally combined to obtain a high resolution image without compromising on the field of view. Such high resolution image is obtained with a high depth of field and without a need for immersion oil to improve magnification.
In Fourier ptychography microscopy, phase information can also be derived computationally from one or more images of the one or more components in the blood sample illuminated at varying illumination angles. Such computational derivation of phase information may be performed using Gerchberg-Saxton algorithm. The phase image obtained from the algorithm enables calculation of key clinical hematological parameters such as hemoglobin concentration and mean corpuscular volume from cell thickness/height. A relationship between phase shift (Δϕ), concentration (C) and height (h) with a spatial dependence in a two-dimensional (x, y) plane is depicted below:
Δϕ(x,y;λ)=k0[β(λ)C(x,y)+Δnws(λ)]h(x,y)
where λ is wavelength of light, Δnws is refractive index difference between water and surrounding media, and β is the rate of change (mg/l) of the refractive index versus protein concentration. Fourier ptychography provides several unique technical advantages over traditional microscopy. Fourier ptychography enables a wide field of view with high resolution using a low magnification/resolution lens or objective lens. The hardware components of Fourier ptychography microscope are simple and mainly require an illumination source which can illuminate at multiple angles. Additionally, Fourier ptychography enables obtaining phase images at multiple wavelengths computationally using image reconstruction algorithms such as Gerchberg-Saxton algorithm.
In an embodiment, the spiral portion 201 of the channel 200 may have five or more loops. The loops may be spaced in the range of, for example, 400-1000 μm. The channel 200 may have a width in the range of, for example, 300 to 600 μm. The plurality of outlets 202 is configured to collect the cone or more components of the blood sample after they are separated in the spiral portion 201. Advantageously, the channel 200 sorts the one or more components in the blood sample, thereby eliminating the need to scan the field of view for required components.
The blood sample may be introduced into the microfluidic chip 300 through the inlet at a bottom-left corner of the microfluidic chip 300. The one or more components in the blood sample follow a diagonal path in the microfluidic chip 300 through combined oscillatory flow and cross flow. Small components, for example RBCs, flow into the outlet at a top corner of the microfluidic chip 300 while the bigger components, for example WBCs, are restricted due to the size and deformability. Therefore, each type of component is directed to a specific outlet. Advantageously, the one or more components in the blood sample are sorted before being analyzed/visualized by the imaging module 110.
The image capturing module 106 may be used to capture one or images of the sorted one or more components in the channel 300. Such images may be processed further to identify the one or more components in the blood sample. In an embodiment, a first threshold associated with the one or more components in the image is identified. The first threshold may be, for example, size of the one or more components in the image. WBCs are bigger in size in comparison to RBCs. Therefore, the first threshold is set such that the WBCs are separated out from the RBCs efficiently. The size of the one or more components may be determined, for example, based on the area or circumference of the components in the image. Such determination may be based on the pixel intensity values associated with cellular boundaries of the one or more components in the image. Advantageously, the device 100 enables accurate identification of components in the image which are of clinical relevance.
The above invention enables visualization of one or more components in the blood sample, in a field of view in the range of, for example, 2000×2000 micron. This eliminates the need for manual or automated scanning of the microfluidic channel 103, 200, 300. The device 100 allows for computational adjustment of focus after images of the one or more components in the blood sample are acquired. Advantageously, the device 100 enables analysis of significantly greater number of components in the blood sample in comparison to devices available in the prior art. Furthermore, the one or more components in the blood sample may be visualized in a single field of view without a requirement of physical scanning of the microfluidic channel.
The foregoing examples have been provided merely for the purpose of explanation and are in no way to be construed as limiting of the present invention disclosed herein. While the invention has been described with reference to various embodiments, it is understood that the words, which have been used herein, are words of description and illustration, rather than words of limitation. Further, although the invention has been described herein with reference to particular means, materials, and embodiments, the invention is not intended to be limited to the particulars disclosed herein; rather, the invention extends to all functionally equivalent structures, methods and uses, such as are within the scope of the appended claims. Those skilled in the art, having the benefit of the teachings of this specification, may effect numerous modifications thereto and changes may be made without departing from the scope and spirit of the invention in its aspects.
This application claims priority to U.S. Provisional Application No. 62/946,068, filed on Dec. 10, 2019. The entire content of the above-referenced patent application is hereby expressly incorporated herein by reference.
Filing Document | Filing Date | Country | Kind |
---|---|---|---|
PCT/US20/63312 | 12/4/2020 | WO |
Number | Date | Country | |
---|---|---|---|
62946068 | Dec 2019 | US |